<DOC>
	<DOCNO>NCT01807624</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics/pharmacodynamics safety nasal spray contain anesthetic drug tetracaine combination oxymetazoline blood draw 24 hour .</brief_summary>
	<brief_title>Safety Pharmacokinetics Kovacaine Nasal Spray ( 24 Hour Blood Collection )</brief_title>
	<detailed_description>The purpose study determine pharmacokinetics safety tetracaine , para- butylaminobenzoic acid ( PBBA ) , oxymetazoline intranasal administration high Phase 3 dose Kovacaine Mist ( Tetracaine Hydrochloride Oxymetazoline Hydrochloride ) healthy volunteer . This open-label , single-treatment , single-dose study healthy volunteer subject receive high Phase 3 dose Kovacaine Mist one occasion . No randomization necessary single treatment , single dose study . A single study center participate . Each subject receive single dose Kovacaine Mist ( 3 % tetracaine HCl 0.05 % oxymetazoline HCl ) consist 3 spray ( 0.2 mL ) one nostril take long 8 minute , total 0.6 mL dose contain 18 mg tetracaine HCl 0.3 mg oxymetazoline HCl . The total dosing period 8 minute . Subjects require fast 10 hour prior dose four ( 4 ) hour dose . Water allow ad lib study except one ( 1 ) hour prior one ( 1 ) hour dose administration . Subjects admit study unit later 2100 hour even prior drug administration remain unit 24 hour blood sample collect discharge procedure complete .</detailed_description>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Male nonpregnant , nonbreastfeeding female subject age 18 75 year ( inclusive ) . Can understand sign inform consent document , communicate investigator , understand comply requirement protocol . Body mass index 18 35 BMI . Sufficiently healthy determine investigator receive test medication undergo schedule study procedure . Can breathe nostril . Screening BP â‰¤ 140/90 mm Hg . History clinically significant respiratory , gastrointestinal , renal , hepatic , neurologic , hematologic , endocrine , oncologic , pulmonary , immunologic , psychiatric , cardiovascular disease , include cardiac arrhythmia , narrow angle glaucoma benign prostatic hypertrophy ( men ) , uncontrolled thyroid disease ( include Hashimoto 's Thyroiditis lymphocytic thyroiditis ) , uncontrolled diabetes mellitus condition , opinion Principal Investigator , would jeopardize safety subject impact validity study result . Has clinically significant abnormal finding physical examination , medical history , electrocardiogram ( ECG ) , clinical laboratory evaluation screening . This include current upper respiratory infection . Currently experience seasonal perennial allergic rhinitis , recurrent nosebleed asthma , significant history condition , opinion Investigator . Current , include last 30 day , sinusitis upper respiratory infection . Nasal polyp , significant nasal sinus surgery abnormality may interfere dose administration . History allergic adverse response tetracaine , ester local anesthetic , PBBA , oxymetazoline preservative , paraaminobenzoic acid find PABA contain sunscreen comparable similar product . Donation blood plasma within 30 day first dose Study Drug . Participation clinical trial within 30 day prior first dose Study Drug . Use new overthecounter ( OTC ) medication , include topical anesthetic cream gel , vitamin , within seven day prior first dose Study Drug study unless approve Principal Investigator . Any prescription medication , whose dose stable time screening , determine Principal Investigator . Treatment known enzyme alter drug barbiturate , phenothiazine , cimetidine , carbamazepine , etc. , within 30 day prior first dose Study Drug study . Smoking use tobacco product within 6 month prior first dose Study Drug study . Female try conceive , pregnant , suspected pregnant , lactate . ( Females childbearing potential require take serum pregnancy test screening ( 21 day prior start study , include day study ) , well urine pregnancy test checkin rule pregnancy . ) Positive serum pregnancy test screen urine pregnancy test checkin woman childbearing potential . Positive blood screen HIV , Hepatitis B surface antigen ( HbSAg ) , Hepatitis C , positive urine screen alcohol , drug abuse , cotinine . Have history pseudocholinesterase deficiency previous prolonged paralysis succinylcholine difficulty wake general anesthesia . Have history alcoholism and/or drug abuse . Have take monoamine oxidase inhibitor vasopressor drug within past 3 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Pharmacokinetic</keyword>
</DOC>